MedTrace Logo

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

NCT03871790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-02-10

No results posted yet for this study

Summary

An international, multicenter study to identify tumor molecular particularities and neoepitopes among participants with colorectal and pancreatic tumors undergoing surgery.

Conditions

  • Colon Neoplasm
  • Colon Adenocarcinoma
  • Colon Cancer
  • Colo-rectal Cancer
  • Rectal Cancer
  • Rectal Neoplasms
  • Rectal Adenocarcinoma
  • Rectal Tumors
  • Pancreatic Cancer
  • Pancreas Cancer
  • Pancreatic Neoplasms
  • Pancreatic Adenocarcinoma

Sponsors & Collaborators

  • CENTOGENE GmbH Rostock

    lead INDUSTRY

Principal Investigators

  • Peter Bauer, Prof. · CENTOGENE GmbH Rostock

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2022-04-01
Completion
2022-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03871790 on ClinicalTrials.gov